GUERBET (GBT.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:GBT - FR0000032526 - Common Stock
14.8 EUR
+0.2 (+1.37%)
Overall GBT gets a fundamental rating of 4 out of 10. We evaluated GBT against 68 industry peers in the Health Care Equipment & Supplies industry. While GBT seems to be doing ok healthwise, there are quite some concerns on its profitability. GBT has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
GBT had positive earnings in the past year.
GBT had a positive operating cash flow in the past year.
GBT had positive earnings in 4 of the past 5 years.
GBT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of GBT (0.76%) is worse than 60.00% of its industry peers.
Looking at the Return On Equity, with a value of 2.06%, GBT is doing worse than 60.00% of the companies in the same industry.
GBT's Return On Invested Capital of 3.15% is on the low side compared to the rest of the industry. GBT is outperformed by 63.08% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GBT is significantly below the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 2.06% | ||
| ROIC | 3.15% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
1.3 Margins
GBT has a worse Profit Margin (0.96%) than 60.00% of its industry peers.
GBT's Profit Margin has declined in the last couple of years.
GBT has a worse Operating Margin (4.19%) than 63.08% of its industry peers.
GBT's Operating Margin has declined in the last couple of years.
The Gross Margin of GBT (78.03%) is better than 90.77% of its industry peers.
GBT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.19% | ||
| PM (TTM) | 0.96% | ||
| GM | 78.03% |
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GBT is destroying value.
GBT has about the same amout of shares outstanding than it did 1 year ago.
GBT has more shares outstanding than it did 5 years ago.
GBT has a worse debt/assets ratio than last year.
2.2 Solvency
GBT has an Altman-Z score of 2.07. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of GBT (2.07) is comparable to the rest of the industry.
The Debt to FCF ratio of GBT is 8.94, which is on the high side as it means it would take GBT, 8.94 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of GBT (8.94) is comparable to the rest of the industry.
GBT has a Debt/Equity ratio of 0.93. This is a neutral value indicating GBT is somewhat dependend on debt financing.
GBT has a worse Debt to Equity ratio (0.93) than 75.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 8.94 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.47
WACC6.73%
2.3 Liquidity
GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
GBT's Current ratio of 2.32 is fine compared to the rest of the industry. GBT outperforms 69.23% of its industry peers.
GBT has a Quick Ratio of 1.03. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
GBT has a Quick ratio (1.03) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
GBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.27%.
The earnings per share for GBT have been decreasing by -15.50% on average. This is quite bad
Looking at the last year, GBT shows a decrease in Revenue. The Revenue has decreased by -2.01% in the last year.
Measured over the past years, GBT shows a small growth in Revenue. The Revenue has been growing by 0.59% on average per year.
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
3.2 Future
Based on estimates for the next years, GBT will show a decrease in Earnings Per Share. The EPS will decrease by -5.56% on average per year.
Based on estimates for the next years, GBT will show a small growth in Revenue. The Revenue will grow by 3.86% on average per year.
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 24.67, GBT is valued on the expensive side.
GBT's Price/Earnings ratio is a bit cheaper when compared to the industry. GBT is cheaper than 73.85% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.19. GBT is around the same levels.
GBT is valuated reasonably with a Price/Forward Earnings ratio of 10.13.
92.31% of the companies in the same industry are more expensive than GBT, based on the Price/Forward Earnings ratio.
GBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.67 | ||
| Fwd PE | 10.13 |
4.2 Price Multiples
95.38% of the companies in the same industry are more expensive than GBT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, GBT is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.2 | ||
| EV/EBITDA | 4 |
4.3 Compensation for Growth
A cheap valuation may be justified as GBT's earnings are expected to decrease with -10.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
5. Dividend
5.1 Amount
GBT has a Yearly Dividend Yield of 2.69%.
GBT's Dividend Yield is rather good when compared to the industry average which is at 1.13. GBT pays more dividend than 90.77% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, GBT pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
81.59% of the earnings are spent on dividend by GBT. This is not a sustainable payout ratio.
GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP81.59%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPA:GBT (1/9/2026, 7:00:00 PM)
14.8
+0.2 (+1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.22%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap187.07M
Revenue(TTM)809.67M
Net Income(TTM)7.73M
Analysts44
Price Target15.56 (5.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.59%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.9%
Revenue NY rev (3m)-1.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.67 | ||
| Fwd PE | 10.13 | ||
| P/S | 0.23 | ||
| P/FCF | 4.2 | ||
| P/OCF | 2 | ||
| P/B | 0.5 | ||
| P/tB | 0.68 | ||
| EV/EBITDA | 4 |
EPS(TTM)0.6
EY4.05%
EPS(NY)1.46
Fwd EY9.87%
FCF(TTM)3.53
FCFY23.83%
OCF(TTM)7.4
OCFY50.01%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 2.06% | ||
| ROCE | 4.45% | ||
| ROIC | 3.15% | ||
| ROICexc | 3.64% | ||
| ROICexgc | 4.3% | ||
| OM | 4.19% | ||
| PM (TTM) | 0.96% | ||
| GM | 78.03% | ||
| FCFM | 5.51% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 8.94 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 66.71% | ||
| Cap/Sales | 6.05% | ||
| Interest Coverage | 1.56 | ||
| Cash Conversion | 87.13% | ||
| Profit Quality | 576.4% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.07 |
F-Score5
WACC6.73%
ROIC/WACC0.47
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%
EBIT growth 1Y-42.07%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year50.63%
EBIT Next 3Y21.02%
EBIT Next 5Y21.78%
FCF growth 1Y182.18%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2940.2%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%
GUERBET / GBT.PA FAQ
What is the fundamental rating for GBT stock?
ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.
What is the valuation status of GUERBET (GBT.PA) stock?
ChartMill assigns a valuation rating of 5 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.
How profitable is GUERBET (GBT.PA) stock?
GUERBET (GBT.PA) has a profitability rating of 3 / 10.
What is the financial health of GUERBET (GBT.PA) stock?
The financial health rating of GUERBET (GBT.PA) is 4 / 10.
Is the dividend of GUERBET sustainable?
The dividend rating of GUERBET (GBT.PA) is 4 / 10 and the dividend payout ratio is 81.59%.